1.Rosenberg S.A., Yang J.C., Restifo N.P. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 2004; 10: 909Œ15.2.Blattman J.N., Greenberg P.D. Cancer immunotherapy: a treatment for the masses. Science 2004; 305(5681): 200-5.3.Bregni M., Ueno N.T., Childs R. The Second International Meeting on Allogeneic Transplantation in Solid Tumors. Bone Marrow Transplant. 2006; AOP Sep 4.4.Rosenberg S.A., Spiess P., Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986; 233(4770): 1318-21.5.Mule J.J., Shu S., Schwarz S.L., Rosenberg S.A. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin- 2. Science 1984; 225(4669): 1487-9.6.Rosenberg S.A. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity. 1999; 10(3): 281-7.7.Dudley M.E., Wunderlich J..R, Robbins P.F. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298(5594): 850-4.8.Dudley M.E., Wunderlich J.R., Yang J.C. et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 2005; 23(10): 2346-57.